Lv22
114 积分 2022-12-28 加入
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
1小时前
已完结
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients
1小时前
已完结
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B‐Cell Lymphoma: A Real‐World, Multi‐Center, Retrospective Cohort Study
1小时前
已完结
Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world
2小时前
已完结
Neonatal and infant infection with SARS-CoV-2
9天前
已完结
Association of valproic acid-related pharmacodynamics, pharmacokinetic pathways and transporter gene polymorphisms and antiepileptic efficacy in Chinese Patients
1个月前
已完结
Intra-individual Pharmacokinetic Variability of Intravenous Busulfan in Hematopoietic Stem Cell-Transplanted Children
1个月前
已完结
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring
1个月前
已完结
Implementation and evaluation of busulfan pharmacokinetics in adult hematopoietic stem cell transplantation
1个月前
已完结
Therapeutic drug monitoring of intravenous busulfan in Thai children undergoing hematopoietic stem cell transplantation: A pilot study
1个月前
已完结
皖公网安备34019202002308
